Call for Abstract

2nd International Conference on Oncodiagnostics and Cancer Research, will be organized around the theme “Together we can win over cancer”

Cancer diagnostics Conference 2019 is comprised of keynote and speakers sessions on latest cutting edge research designed to offer comprehensive global discussions that address current issues in Cancer diagnostics Conference 2019

Submit your abstract to any of the mentioned tracks.

Register now for the conference by choosing an appropriate package suitable to you.

The method of understanding the cancer disease is quite clear. Cancer is an exponential growth of abnormal cells in the body. It will get progressed when the body's normal control system quits working. Old cells don't lapse and rather grow in an exponential manner, leading to the development of new, abnormal cells. These additional cells may change into a mass of tissue, called a tumour. Some cancers, like leukaemia, don't shape into a tumour.


  • Track 1-1Abnormal cell growth
  • Track 1-2Medical oncology
  • Track 1-3Hematologic oncology
  • Track 1-4Neuro Oncology
  • Track 1-5Surgical oncology
  • Track 1-6Thoracic Oncology
  • Track 1-7Radiation oncology
  • Track 1-8Gynaecologic oncology

Throughout the world, carcinoma is the principle origin of death. Its recurrence is exhibiting a growing shape in various parts of the earth and has been a critical general medicinal issue. Cancers are distinguished by the area of origination in the host body. Till date, 100+ kinds of tumours have been recognized and the exploration on the same is proceeding.


  • Track 2-1Thyroid and liver Carcinoma
  • Track 2-2Brain and Paranasal Sinus Cancer
  • Track 2-3Dermatological Carcinoma
  • Track 2-4Breast and Cervical Carcinoma
  • Track 2-5Head and Neck Carcinoma
  • Track 2-6Pulmonary and Renal Carcinoma
  • Track 2-7Reproductive Carcinoma
  • Track 2-8Lung Cancer
  • Track 2-9Melanoma

Cancer is the uncontrolled development of the host cell. This abnormal growth frequently results in the development of a swelling   which is named as Tumor. Cancer Cell Biology manages with the entire functioning of the cancer cell in the host. This includes finding the reason for the abnormal functioning of the cancerous cells, how these malignancy cells divide in an uncontrolled manner and move to different organs, cell development, metastasis, their impact on normal organ functioning, the capacity of the host immune system in controlling it and so on. To comprehend all these prospects one needs to think about these cells at the sub-atomic level. Signalling between the cells holds the answer for all these. In spite of the fact that the ongoing exploration on these has uncovered many questions related to the cancer growth, diagnosis, cure and Management, answers are discovered just by understanding the essential information acquired after investigating the Biology of these Cancer Cells.


  • Track 3-1Research on Causes of Cancer
  • Track 3-2Opportunities in Cancer Biology Research
  • Track 3-3Cancer therapeutic resistance
  • Track 3-4Pharmacologic Treatments
  • Track 3-5Cancer Genomics
  • Track 3-6Statistical and mechanistic modelling of cancer development

The term paediatric oncology includes all cancerous disorders among the children with cancer including blood conditions such as leukaemia. A large portion of the cancers influencing children’s contrast from those influencing adults. They happen in various parts of the body; occur in a different way under the optical microscope and react distinctively to the treatment. Treatment is often difficult and exhaustive but the rate of getting cured amongst the  children are much more higher than for most adult cancers, and largely over 70% of kids are entirely alleviated. A major part of these will encounter continuing reactions from their treatment. Children’s are diagnosed with an extensive variety of malignancies in the UK; around 41% are leukaemia and lymphomas, 25% brain cancer, with the rest of the conditions involving an extensive variety of tumours.


  • Track 4-1Focus on translational research
  • Track 4-2New approaches to sarcoma research
  • Track 4-3Advancing our understanding of neuroblastoma
  • Track 4-4Genomic approaches to drug discovery
  • Track 4-5Harnessing the immune system to fight cancer
  • Track 4-6Ewing sarcoma
  • Track 4-7Stem cell treatment research
  • Track 4-8Attacking brain tumours

Oncology nurses work in a multi-disciplinary group. Oncology nurses routinely fill in as your first line of correspondence and help sort out the various parts of care all through tumour treatment. They may play out different commitments. An Oncology Nurse offers attention to cancer patients and to those who are in risk of getting the disease. Oncology medicinal nurses must direct to both the symptoms of a patient's illness and the responses of various tumour medicines. They screen physical conditions, recommend medicine, and control chemotherapy and different medicines.


  • Track 5-1Preventive oncology
  • Track 5-2Cancer Care and Psychological Support
  • Track 5-3Palliative care: Cancer
  • Track 5-4Nurse Practitioner Education
  • Track 5-5Advances in Online Nursing Classes
  • Track 5-6Evidence Based Practice in Nursing
  • Track 5-7Supportive Care Services

A Biopsy is the removal of a minute amount of tissue from the body for analysis under a microscope by a pathologist and can similarly be anatomised synthetically. Other tests like imaging is useful in identifying an area of abnormality, they can't separate between a Cancer cell and normal cell, only Biopsy performs convincing analysis of Cancer. The method of removing the entire lump is called as an excisional biopsy. The method of removing only the small portion of tissue is known as an incisional biopsy.


  • Track 6-1Innovation Therapies in Biopsy
  • Track 6-2Analysing Cancer Biopsy
  • Track 6-3Sentinel Lymph Node Mapping
  • Track 6-4Surgical Biopsy
  • Track 6-5Eosinophil in inflammatory infiltrate
  • Track 6-6Lung biopsy
  • Track 6-7Liver biopsy
  • Track 6-8Prostate biopsy

Diagnostic testing includes tests and techniques to affirm the correct tumour type, area, stage and also the extent of the disease in the host cell. In order to develop a proper treatment, an exhaustive and precise cancer growth analysis should be done. An entire diversity of diagnostics tests affirms the analysis and individualized treatment. The advancement of most recent tools and techniques in the analysis of cancer growth can assist the specialists to cure the cancer disease in early stage itself.


  • Track 7-1Advancement in Diagnostic Tools and Technniques
  • Track 7-2Cancer Diagnostic Market
  • Track 7-3Radiology Test
  • Track 7-4Genomic Testing
  • Track 7-5CT Scan
  • Track 7-6Endoscopy
  • Track 7-7MRI
  • Track 7-8X- Ray
  • Track 7-9PET Test
  • Track 7-10Ultrasound

There are various ways by which we can lower the risk of getting cancer: by maintaining a healthy lifestyle, by preventing yourself from exposure to carcinogenic substance, and taking immunizations or drugs at cautionary level. Cancer occurs mainly due to mutation i.e. a change in the structure of the genes that control our body functions. Tobacco use is directly connected with 33% of all cancers. Tobacco smoking can significantly enhance the danger of lung, kidney, bladder, and head and neck tumour. In 2017, more than 1.6 million people were diagnosed with cancer in USA. Malignancy is certainly not a solitary disease yet a cluster of certain different diseases related with it. Various causes of cancer, its inhibition and early identification are principle focal point of the session.


  • Track 8-1Cancer Vaccines
  • Track 8-2Carcinogens
  • Track 8-3 Cancer Risk
  • Track 8-4Precancerous conditions
  • Track 8-5Imaging Test
  • Track 8-6Blood Tests
  • Track 8-7Scanning
  • Track 8-8Cancer Biopsy

Cancer Immunology is a branch of research science that targets to determine the cancer immunotherapies in order to cure the disease and also to inhibit the progression of the disease. The reaction of immune system, including the recognition of cancer-specific antigens, develops the origin of targeted and tumour marker-based diagnostic tests. In order to develop new therapies for the cancer treatment, a thorough understanding of all these interaction plays a vital role. In Immunotherapy a person’s own immune system is used to fight with the can be achieved in various ways: Own immune system stimulation, Biological therapy or biotherapy. After a long term research on the immune system, cancer immunotherapy has achieved a great advancement today. Currently many investigations on the immune system are going on: understand why immunotherapy does not show the same result in every cancer patients, expansion of the use of immunotherapy to a wide variety of cancer, augment the efficacy of immunotherapy by merging it with other types of cancer treatment, such as radiation therapy, chemotherapy and targeted therapy.


  • Track 9-1Tumor Immunology
  • Track 9-2Immune checkpoint inhibitors
  • Track 9-3Immuno-Oncology studies
  • Track 9-4Cancer Immunosurveillance
  • Track 9-5Tumour Immunogenicity
  • Track 9-6Cancer-Specific Antigens
  • Track 9-7Combining radiotherapy
  • Track 9-8Cancer Immunology and Chemotherapy
  • Track 9-9Rationale for immunotherapy

Nanotechnology, an emerging arena in the field of cancer diagnostics and cancer research is facilitating the researchers to monitor the molecules and structures of minute sizes in order to increase our ability to detect, examine and destroy the cancerous cells in the body. Scientists have investigated Nano sized particles and devices. Due to their minute size, Nano therapeutics can travel everywhere in the body, as well as slide within the cells, thereby conveying medication or identifying disease in ways unimagined before now. The minute size of Nano devices, such as mechanical, chemical, or electronic sensors, combined with refined microscopic plumbing systems, are permitting scientists to examine a host of atomic and physical characteristics from individual cells. Their ability to attain their targets so precisely and proficiently permits the doctors to utilize smaller doses that are less toxic. Since they can enter cells, nanoparticles are useful carriers for drugs that work inside the cell.


  • Track 10-1Nanothearanostics
  • Track 10-2Nano sensors
  • Track 10-3Nano vectors
  • Track 10-4Nano medicine
  • Track 10-5Nano bullets
  • Track 10-6Cancer Metabolomics and Biomarkers
  • Track 10-7Nanotechnology in cancer therapy

Diagnosis of cancer at an early stage could greatly improve the chances of survival for many patients. The first step in developing an individualized cancer treatment strategy is to have an accurate and full knowledge on cancer diagnosis. When you first visit hospital, we will perform a lot of clinical tests to effectively affirm your disease and strategize your own specific treatment. Diagnostic analysis includes tests and procedures to verify the disease and recognize the tumour type, site, amount and stage. Its multidisciplinary method allows readers to keep up-to-date with challenges and development in their own as well as related fields. Cancer meetings also focused on these topics.


  • Track 11-1Next-gene sequencing of cancers
  • Track 11-2Biobank for cancer research & treatment
  • Track 11-3High resolution micro endoscopy
  • Track 11-4CryoPen & cryotherapy device
  • Track 11-5Portable computer-aided detection
  • Track 11-6Non-invasive cancer diagnostics
  • Track 11-7MR guided Focused Ultrasound Surgery
  • Track 11-8Camera pill technology in cancer detection
  • Track 11-93D printing technology in cancer detection

The global cancer diagnostics market scope was valued at USD 124.0 billion in 2016 and is expected to grow at a CAGR of 7.2% over the forecast period. Forced diagnostics advancements have accomplished a decreasing of 30% in breast cancer. Henceforward, the imaging part in the worldwide Oncological diagnostics market will continue with its everlasting within a reasonable time-frame. The overall Cancer Diagnostics Market can be portioned into blood cancer, kidney disease, breast cancer, prostate growth, pancreatic growth, ovarian tumour, lung cancer, and liver cancer. The worldwide cancer diagnostics market is generally estimated by improving the interest for lung cancer and breast cancer analysis. The lung cancer section is driving the market, as it is the most predominant kind of malignancy.


  • Track 12-1Novel trends in cancer diagnostics
  • Track 12-2Growth of cancer diagnostics
  • Track 12-3Commercialization of cancer diagnostics
  • Track 12-4Business of cancer diagnostics
  • Track 12-5Tumour Biomarkers tests
  • Track 12-6Breast Cancer Biomarkers
  • Track 12-7Advancement in Cancer Biomarker

Diagnostic radiology helps health care specialists to monitor the frame-works inside your body. Experts that have practical knowledge in the interpretation of these structures are called diagnostic radiologists. Utilizing the symptomatic structures or images, the radiologist or doctors can often diagnose abnormalities. The most widely recognized type of analytic radiologic tests include Computed tomography (CT), otherwise called a CAT scan (computerized axial tomography), including Fluoroscopy ,CT angiography , Magnetic resonance imaging (MRI) and Mammography, including upper GI and barium enema, Nuclear medicine, Magnetic resonance angiography (MRA),  which incorporates such tests as thyroid scan,  bone scan,  and thallium cardiac stress test, Plain x-rays, which includes Positron emission tomography, additionally called PET imaging or a PET scan and Ultrasound.


  • Track 13-1MRI Scan
  • Track 13-2Computed Tomography (CT) scan
  • Track 13-3Positron Emission Tomography (PET) scan
  • Track 13-4Mammographic analysis
  • Track 13-5Integrated PET-CT scan
  • Track 13-6PET/MRI versus PET/CT Hybrid

Genomic analysis is the basis of developing cancer in a generation. It can be achieved by finding the particular changes that occur in your genetic factor, proteins, DNAs. This alteration is said to be a mutation. Breast cancer, ovarian cancer, Colon, as well as thyroid will enable genetic testing to identify the disease in our body. No hereditary test can be able to state the advancement of malignancy. In any case, this test will assist you with cautioning about the danger of progression in malignancy.     


  • Track 14-1Diagnostic testing
  • Track 14-2Predictive gene testing
  • Track 14-3Molecular Oncology
  • Track 14-4Innovation in Genetic Testing
  • Track 14-5Innovation in Genetic Testing
  • Track 14-6Presymptomatic gene testing
  • Track 14-7NGS Testing
  • Track 14-8TNM organizing framework
  • Track 14-9Recurrence
  • Track 14-10Autopsy

Biomarkers are the Biological indicators which are used to identify the presence of tumour in the early stages. Biomarkers offer a dynamic way to deal with understanding the range of tumours with applications in observational and rational study of disease transmission, randomized clinical trials, screening, analysis, and detection. Biomarkers have numerous potential applications in oncology, including differential analysis, screening, estimation of response to treatment, risk factors evaluation determination of diagnosis, and monitoring of progression of disease. Because of the critical role that biomarkers play at all stages of disease, it is imperative that they undergo thorough assessment, including scientific approval, clinical approval, and evaluation of clinical utility, before its introduction into routine clinical care.


  • Track 15-1Genetic Biomarker
  • Track 15-2Epigenetic Biomarkers
  • Track 15-3Proteomic Biomarker
  • Track 15-4Imaging Biomarkers
  • Track 15-5Gene based Biomarkers
  • Track 15-6Nucleic acid based Biomarkers
  • Track 15-7Protein based Biomarkers
  • Track 15-8Clinical Application of Biomarkers
  • Track 15-9Biomarkers in Radiology
  • Track 15-10Molecular Biomarkers

Mostly medicines from the chemical origin are used to treat cancer. Till date, they are believed to be the most established sources for the medicines .In any case, because of the reactions and the cost engaged with the improvement makes it hard to be accessible for everybody. This is where the alternative medicines come into the light. Alternative medicines can be of natural sources, therapy etc. They are either provided in supplement with the chemical drugs or prescribed separately. One must take it to the note that alternative medicines may not be very efficient in killing the cancer cells but considering the toxic effects which it has on the host and affordability, they are being popularized now around the globe.        


  • Track 16-1Acupuncture
  • Track 16-2Cannabis and Cannabinoids
  • Track 16-3Mind-Body Therapies
  • Track 16-4Nutritional Therapies
  • Track 16-5Botanicals/Herbal Products
  • Track 16-6Ayurvedic treatment for cancer
  • Track 16-7Cancer and herbal medicine
  • Track 16-8Naturpathy and cancer
  • Track 16-9Homeopathy and cancer

Clinical trials are the concluding stage in a lengthy procedure that commences with the examination in a laboratory. Scientists work for many years to understand its effects on cancer cells in the lab and in animals prior to any new treatment on individuals in clinical trials. They also try to figure out the side effects it may cause. Clinical Research comprises of many phases where drug molecules are examined with the help of computational tools and then later they are approved for the trials on the animals and human. The trials executed on the animals and individuals are termed as Clinical Trials, which is considered to be the final and the vital step in the Drug development cycle. Once the drug is proven to be effective and not harmful, it is approved to be released into the market.


  • Track 17-1Phase-1:safety of drug
  • Track 17-2Phase-2:efficacy of drug
  • Track 17-3Phase-3:random testing
  • Track 17-4Phase-4:Post Market Surveillance Trials
  • Track 17-5Drug terminology
  • Track 17-6Types of study design
  • Track 17-7Clinical study management
  • Track 17-8Data collection and management
  • Track 17-9Data analysis
  • Track 17-10Results reporting

Innovations in Cancer Research and Oncology unites together foremost researchers working in the fields of cancer treatment, cancer biology, cancer prevention, cancer diagnosis, and regenerative medicine in order to communicate evidence on their recent work and to help shape future analyses. Subjects covered include tissue engineering, drug discovery, and nanotechnology, particularly as they connect to the fields of cancer research. Cancer being one of the lethal maladies in the world, many have made it as main concern to find complete therapy for this. The same reason has made much advancement to be advanced in recent years. Cancer research has taken developments in Radiology to bring better analysis tools, Bioinformatics for emerging improved drug development tools, Surgery to bring better options to achieve minimal invasive methods.


  • Track 18-1Innovative Drug Discovery and Nanotechnology
  • Track 18-2Computer-Aided Drug Design Methods (CADD)
  • Track 18-3Combinatorial Chemistry in Drug Discovery
  • Track 18-4Smart Drug Delivery Systems
  • Track 18-5Structural Biology in Drug Development
  • Track 18-6Cancer polymeric nanotechnology and drug design
  • Track 18-7Oncology case reports
  • Track 18-8Newer strategies of Cancer
  • Track 18-9Proteins in various cancers
  • Track 18-10Anti-cancer Vaccines

The epidemiology of cancer is the study of the cancer causes, control and prevention, as a method to understand possible patterns and causes. The study of disease transmission uses epidemiological approaches to determine the cause for cancer and to identify and produce improved medicines. This area of study must combat with the matters of lead time bias and length time bias. Lead time bias is the indication that initial study may falsely multiply the survival amounts of a cancer, without tremendously improving the consistent history of the illness. Length time bias is the knowledge that slower evolving, more slow cancer will possibly be examined by screening tests; however alterations in analysing more cases of exhausted malignancy may not change into improved patient consequences after the implementation of screening programs. A connected concern is over diagnosis, the tendency of screening tests to analyse disease that may not really affect the patient's life span.


  • Track 19-1Genetic and molecular epidemiology
  • Track 19-2Gene-Environment Interactions
  • Track 19-3Environmental Carcinogens
  • Track 19-4Cancer Etiology
  • Track 19-5Neuroblastoma
  • Track 19-6Neuroblastoma
  • Track 19-7Teratoma
  • Track 19-8Central sensory system malignancies

Medical case reports are the records where the information obtained from the investigation and treatment of an individual is obtained. These usually aid in tracing the recovery of the patient after the treatment. The individual under examination is strictly observed and all the data including sickness, drug regime, drug dose and the lifestyle of the patient are noted. A case report is the complete report of signs, symptoms, diagnosis, and treatments of the particular patients of certain medical history with unique therapeutic approaches. In global cancer conferences various case reports on cancer are discussed. Approximately 7.6 million of new cases of cancer recognized every year, half of them are from developing countries. Case reports need to be up to date from all the records from the past.



  • Track 20-1Cancer Case studies
  • Track 20-2Medical case reports
  • Track 20-3Clinical case reports
  • Track 20-4Cancer in clinical trails
  • Track 20-5Cancer history
  • Track 20-6New associations or variations in disease processes
  • Track 20-7Adverse interactions involving medications
  • Track 20-8Management of new and emerging diseases